Abstract

The synthesis of new bifunctional chelating agents (BFCAs) based on the phosphorus hydrazide ligand family for potential {sup 109}Pd labeling of tumor-localizing biomolecules such as proteins/peptides is described. The new BFCAs were achieved in good yields (75-90%) by the reaction of the phosphorus hydrazide PhP(S)(NMeNH{sub 2}){sub 2} (1) with functionalized aldehydes to yield the Schiff-base products with the following chemical compositions as air-stable crystalline solids: PhP(S)(NMeNH{sub 2})(NMeNCHC{sub 6}H{sub 4}COOH), 2; PhP(S)(NMeNCHC{sub 6}H{sub 4}COOH){sub 2}, 3; PhP(S)(NMeNH{sub 2})(NMeNCHC{sub 6}H{sub 4}CH=CHCOOH), 4; PhP(S)(NMeNCHC{sub 6}H{sub 4}CH-CHCOOH){sub 2}, 5. The reactions of three of the new phosphorus hydrazides (2-4) with PdCl{sub 2}(PhCN){sub 2} resulted in the new Pd(II) metallacycles PhP(S)(NMeNH{sub 2})(NMeNCHC{sub 6}H{sub 4}COOH){center_dot}PdCl{sub 2}, 6; PhP(S)(NMeNCHC{sub 6}H{sub 4}COOH){sub 2}{center_dot}PdCl{sub 2}, 7; and PhP(S)(NMeNH{sub 2})(NMeNCHC{sub 6}H{sub 4}CH=CHCOOH){center_dot}PdCl{sub 2}, 8. The reactivity of 6 toward n-butylamine has been evaluated as a model for the preparation of new bioconjugates. The structural elucidation of all the new compounds has been carried out by analytical and complete NMR ({sup 1}H, {sup 31}P) and IR spectroscopic data. As a representative example, the X-ray structure of one of the Pd(II) complexes, 8, has been determined.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.